Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000289922 | SCV000336701 | uncertain significance | not provided | 2015-10-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002317809 | SCV000850754 | likely benign | Inborn genetic diseases | 2019-05-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Baylor Genetics | RCV001330440 | SCV001522120 | uncertain significance | Intellectual developmental disorder with autism and macrocephaly | 2019-09-06 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Gene |
RCV000289922 | SCV001939447 | benign | not provided | 2020-09-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000289922 | SCV003291349 | likely benign | not provided | 2023-12-19 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001330440 | SCV003831989 | uncertain significance | Intellectual developmental disorder with autism and macrocephaly | 2019-02-04 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000289922 | SCV004129015 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | CHD8: BS2 |
Prevention |
RCV004547687 | SCV004751081 | likely benign | CHD8-related disorder | 2022-02-09 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |